58
Views
14
CrossRef citations to date
0
Altmetric
Introduction

Randomized control trials in ALS: lessons learned

, , , , &
Pages 8-13 | Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Michael E. Bozik, Hiroshi Mitsumoto, Benjamin R. Brooks, Stacy A. Rudnicki, Dan H. Moore, Bing Zhang, Albert Ludolph, Merit E. Cudkowicz, Leonard H. van den Berg, James Mather, Thomas Petzinger$suffix/text()$suffix/text() & Donald Archibald. (2014) A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 406-413.
Read now
Paul Gordon, Philippe Corcia & Vincent Meininger. (2013) New therapy options for amyotrophic lateral sclerosis. Expert Opinion on Pharmacotherapy 14:14, pages 1907-1917.
Read now

Articles from other publishers (12)

Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2018) Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients. Frontiers in Neurology 9.
Crossref
Patricia L. Andres, Margaret (Peggy) Allred, Helen E. Stephens, Mary Proffitt Bunnell, Catherine Siener, Eric A. Macklin, Travis Haines, Robert A. English, Katherine A. Fetterman, Edward J. Kasarskis, Julaine Florence, Zachary Simmons & Merit E. Cudkowicz. (2017) Fixed dynamometry is more sensitive than vital capacity or ALS rating scale. Muscle & Nerve 56:4, pages 710-715.
Crossref
Zamanzima Mazibuko, Yahya E. Choonara, Pradeep Kumar, Lisa C. Du Toit, Girish Modi, Dinesh Naidoo & Viness Pillay. (2015) A Review of the Potential Role of Nano-Enabled Drug Delivery Technologies in Amyotrophic Lateral Sclerosis: Lessons Learned from Other Neurodegenerative Disorders. Journal of Pharmaceutical Sciences 104:4, pages 1213-1229.
Crossref
Rubika Balendra, Ashley Jones, Naheed Jivraj, I Nick Steen, Carolyn A Young, Pamela J Shaw, Martin R Turner, P Nigel Leigh & Ammar Al-Chalabi. (2015) Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials. Journal of Neurology, Neurosurgery & Psychiatry 86:1, pages 45-49.
Crossref
Paul H. Gordon & Vincent Meininger. (2011) How can we improve clinical trials in amyotrophic lateral sclerosis?. Nature Reviews Neurology 7:11, pages 650-654.
Crossref
D H Hwang, H J Lee, I H Park, J I Seok, B G Kim, I S Joo & S U Kim. (2009) Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Therapy 16:10, pages 1234-1244.
Crossref
Adam Czaplinski, Albert A. Yen, Ericka P. Simpson & Stanley H. Appel. (2006) Predictability of disease progression in amyotrophic lateral sclerosis. Muscle & Nerve 34:6, pages 702-708.
Crossref
A. CzaplinskiL. J. HaverkampA. A. YenE. P. SimpsonE. C. LaiS. H. Appel. (2006) The value of database controls in pilot or futility studies in ALS. Neurology 67:10, pages 1827-1832.
Crossref
Diether Lambrechts & Peter Carmeliet. (2006) VEGF at the neurovascular interface: Therapeutic implications for motor neuron disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1762:11-12, pages 1109-1121.
Crossref
Jordan M. Fletcher & Richard A. Hughes. (2006) Novel monocyclic and bicyclic loop mimetics of brain-derived neurotrophic factor. Journal of Peptide Science 12:8, pages 515-524.
Crossref
Diether Lambrechts & Peter Carmeliet. 2006. Gene Therapy of the Central Nervous System. Gene Therapy of the Central Nervous System 239 252 .
Masashi Aoki, Shinsuke Kato, Makiko Nagai & Yasuto Itoyama. (2005) Development of a rat model of amyotrophic lateral sclerosis expressing a human SOD1 transgene. Neuropathology 25:4, pages 365-370.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.